Home/NovalGen/Bharat Thakrar

BT

Bharat Thakrar

Chairman

Therapeutic Areas

Oncology Autoimmune Haematological Metabolic

NovalGen Pipeline

Drug	Indication	Phase
NVG-222	Not Specified (Oncology/Haematological)	Phase 1
Lead Self-Regulating Immunotherapy	Not Specified	Pre-clinical/Phase 1

Leadership Team at NovalGen

Professor Amit Nathwani

Chief Executive Officer

Dr. David Granger

View full NovalGen profile